Before and after the administration of propofol or ketamine measurements of DPOAE and TEOAE will be performed
Effects of Ketamine and Propofol in Otoacoustic Emissions (OAE) in Children
Brief Summary
Otoacoustic emissions (OAEs) are non-invasive, easy to apply and objective test methods which are widely used to determine the presence of hearing in audiology clinics. Under some circumstances and children, the study should be applied under general anaesthesia. The aim of this study was to find out the influence of propofol (P) and ketamine (K) on OAE measurements. .
Methods: Thirty- healthy children who will underwent adenoidectomy and tonsillectomy will be included in this study after Institutional ethics committee approval and informed consent of parents. Children will be evaluated one day before surgery by tympanometry. Psychologically prepared children will be admitted to the operating room. Following EMLA (Eutectic Mixture of Local Anesthetics ) cream application IV line will be inserted. ECG and non-invasive blood pressure will be monitored. Transient evoked otoacoustic emissions (TEOAEs) and distortion product otoacoustic emissions (DPOAEs) will measured in both ears of each patient (n=20 ears) prior to P or K administration( Pre-P and Pre-K). Propofol will be given 2mg/kg or ketamine 2mg/kg intravenously and 40% O2 in air will be given by mask ventilation. Five minutes later TEOAE and DPOAE measurements will be repeated (Post-P and Post-K). After this measurement the routine general anaesthesia and surgical protocol will be commenced. Heart rate, blood pressures TEOAE and DPOAE measurements will be compared at pre and post stages by paired Student's t- test.
Condition or Disease
- Normal Healthy Ears
- Ketamine and Propofol Effects on Hemodynamics
- Ketamine and Propofol Effects on TEOAE and DPOAE
Phase
Study Design
Study type: | OBSERVATIONAL |
---|---|
Status: | Completed |
Study results: | No Results Available |
Age: | 4 Years to 15 Years |
Enrollment: | 30 (ACTUAL) |
Funded by: | Other |
Time Perspective: | Prospective |
Observational Model: | Cohort |
Masking |
Clinical Trial Dates
Start date: | Dec 01, 2013 | |
---|---|---|
Primary Completion: | Jan 01, 2015 | ACTUAL |
Completion Date: | Jan 01, 2015 | ACTUAL |
Study First Posted: | Feb 23, 2015 | ESTIMATED |
Results First Posted: | Aug 31, 2020 | |
Last Updated: | Feb 15, 2015 |
Sponsors / Collaborators
Lead Sponsor:
N/A
Responsible Party:
N/A
Location
Eligibility Criteria
Sex: | All |
---|---|
Minimum Age: | 4 |
Maximum Age: | 15 |
Healthy Volunteers: | Yes |
Inclusion Criteria:
children ages 4-15 years ASA ( American Society of Anesthesiologists) I-II Tonsillectomy and/or adenoidectomy Normal ear hearing tests
Exclusion Criteria:
Abnormal hearing tests Abnormal laboratory (Electrolyte imbalance, anemia, polycythemia, thrombocytopenia, leucopenia , leucocytosis) Congenital abnormalities and previous systemic diseases Hypo or hyperthermia Ear operations Long term fasting, dehydration or over hydration Upper respiratory disease, acute or chronic otitis,
children ages 4-15 years ASA ( American Society of Anesthesiologists) I-II Tonsillectomy and/or adenoidectomy Normal ear hearing tests
Exclusion Criteria:
Abnormal hearing tests Abnormal laboratory (Electrolyte imbalance, anemia, polycythemia, thrombocytopenia, leucopenia , leucocytosis) Congenital abnormalities and previous systemic diseases Hypo or hyperthermia Ear operations Long term fasting, dehydration or over hydration Upper respiratory disease, acute or chronic otitis,
Primary Outcomes
More Details
NCT Number: | NCT02368782 |
---|---|
Acronym: | OAE |
Other IDs: | 30112011 |
Study URL: | https://clinicaltrials.gov/study/NCT02368782 |
Last updated: Sep 29, 2023